These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study. Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329 [TBL] [Abstract][Full Text] [Related]
4. Garenoxacin pharmacokinetics in subjects with renal impairment. Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746 [TBL] [Abstract][Full Text] [Related]
5. The effect of peritoneal dialysis method on residual renal function in children. Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226 [TBL] [Abstract][Full Text] [Related]
6. Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis. Bohjanen PR; Johnson MD; Szczech LA; Wray DW; Petros WP; Miller CR; Hicks CB Antimicrob Agents Chemother; 2002 Aug; 46(8):2387-92. PubMed ID: 12121909 [TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetics of lamivudine in end-stage kidney failure persons with detectable and undetectable HIV-1 RNA in peritoneal dialysis effluent. Mooko T; Bisiwe FB; Mondleki E; Morobadi MD; Chikobvu P; Nyaga MM; Bala A; Goedhals D; Mofokeng TRP; Kemp G; Ndlovu KCZ Eur J Med Res; 2024 Jul; 29(1):374. PubMed ID: 39026368 [TBL] [Abstract][Full Text] [Related]
8. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients. Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934 [TBL] [Abstract][Full Text] [Related]
9. Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences? Balasubramanian G; McKitty K; Fan SL Nephrol Dial Transplant; 2011 May; 26(5):1702-8. PubMed ID: 20921296 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Robson R; Buttimore A; Lynn K; Brewster M; Ward P Nephrol Dial Transplant; 2006 Sep; 21(9):2556-62. PubMed ID: 16799169 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal membrane characteristics in patients on peritoneal dialysis. Al-wakeel J; Al-Ghonaim M; Al-Suwaida A; Askar A; Usama S; Feraz N; Shah IH; Memon N; Qudsi A; Sulaimani F Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):49-53. PubMed ID: 21196612 [TBL] [Abstract][Full Text] [Related]
13. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV Nephrol Dial Transplant; 2010 Jun; 25(6):1973-9. PubMed ID: 20097847 [TBL] [Abstract][Full Text] [Related]
14. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients. Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138 [TBL] [Abstract][Full Text] [Related]
15. Phosphate clearance in peritoneal dialysis: automated PD compared with continuous ambulatory PD. Sawin DA; Himmele R; Diaz-Buxo JA Adv Perit Dial; 2012; 28():120-5. PubMed ID: 23311227 [TBL] [Abstract][Full Text] [Related]
16. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options]. Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261 [TBL] [Abstract][Full Text] [Related]
17. Automated peritoneal dialysis: new implications for pharmacists. Brophy DF; Mueller BA Ann Pharmacother; 1997 Jun; 31(6):756-64. PubMed ID: 9184718 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study. Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794 [TBL] [Abstract][Full Text] [Related]
19. Outcome and complications in peritoneal dialysis patients: a five-year single center experience. Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621 [TBL] [Abstract][Full Text] [Related]
20. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center]. Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]